82
51
Growth Score
-4 pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1060058
EirGen Pharma focuses on the development, registration and commercial manufacture of high potency,
About the Company
EirGen Pharma focuses on the development, registration and commercial manufacture of high potency, high barrier to entry solid dose products for the global pharmaceutical market. EirGen Pharma is fully licensed to manufacture oncology, cytotoxic, steroidal and immunosuppressant molecules in a purpose built high containment facility. The state of
the art facilities can also handle the development of moisture sensitive molecules in a low humidity environment. The company has an Investigational Medicinal Products (IMP) licence for the manufacture of clinical trial materials and a Manufacturing Licence for commercial manufacturing and packaging.
